Getfirstperson

Getfirstperson sells direct-to-consumer nutritional gummies and powders focused on sleep, stress, cognition, immunity, and metabolic health. Single SKUs cost $29–$49 for a 30-day supply; bundles drop the per-unit price to the low-$20s. The company is online-only, shipping from U.S. fulfillment centers to all 50 states and Canada. The brand’s hook is “micro-dosing” functional ingredients—each gummy contains low, precise amounts of compounds such as 1 mg melatonin, 100 mg GABA, or 150 mg magnesium so consumers can stack or titrate without over-loading. All formulas are vegan, sugar-free, dyed with fruit juice, and manufactured in NSF-certified facilities; every lot is third-party tested and posted on-site as a COA. Best-sellers include the sleep gummy “Deep Sleep” and the nootropic powder “Focus,” which routinely sell out within days of restock. Core buyers are 25-40-year-old urban professionals who track sleep scores, HRV, and glucose and want bio-optimization without swallowing 10 pills. They value transparent labeling, clean ingredients, and the ability to personalize a stack by mixing two or three low-dose SKUs instead of taking a high-dose single pill. Getfirstperson competes in the crowded “better-for-you” supplement space against both legacy vitamin giants and newer digitally-native pill brands. It differentiates by offering only low-dose, gummy-first formats, publishing complete lab data, and positioning itself as a modular system rather than a one-size-fits-all multivitamin.